Skip to main content
. 2021 Dec 8;25(4):264–269. doi: 10.5114/wo.2021.111310

Table 3.

Treatment type characteristics

  Pre-pandemic period,
n (%)
N = 278
COVID-19 period,
n (%)
N = 340
p-value
Primary surgical treatment 157 (71) 172 (75.4) 0.337
Primary surgical treatment in early stage (T1–T2) laryngeal cancer 29 (80.5) 40 (74) 0.613
Primary surgical treatment in early stage (T1–T2) oropharyngeal cancer 9 (47.3) 26 (86.6) 0.001
Palliative radiotherapy 57 (20.5) 112 (32.9) 0.001
Ineligible for treatment (best supportive care only) 5 (1.8) 21 (6.2) 0.007